Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.42 USD
+0.15 (0.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $65.42 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 321 - 340 ( 521 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Sector Analysis Update: Clinical News Drives Vet Biotech Stock Performance
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Get Cash Ready for Deals-Buy
Provider: G.RESEARCH, LLC
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
We are highlighting GILD as our top biotech pick and believe GILD is the most undervalued stock in the biotech industry.
Provider: G.RESEARCH, LLC
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Zero Hep C Royalty - Buy
Provider: G.RESEARCH, LLC
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating our coverage on Gilead Sciences with a Buy recommendation
Provider: G.RESEARCH, LLC
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended May 6
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended April 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Emerging Perspectives On Drug Pricing
Provider: H.C. Wainwright & Co., Inc.
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 4
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Feb 26
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D